PL2686334T3 - Chromatografia jonowymienna o ulepszonej selektywności do rozdzielania monomerów, agregatów i fragmentów polipeptydowych przez modulację fazy ruchomej - Google Patents

Chromatografia jonowymienna o ulepszonej selektywności do rozdzielania monomerów, agregatów i fragmentów polipeptydowych przez modulację fazy ruchomej

Info

Publication number
PL2686334T3
PL2686334T3 PL12708546T PL12708546T PL2686334T3 PL 2686334 T3 PL2686334 T3 PL 2686334T3 PL 12708546 T PL12708546 T PL 12708546T PL 12708546 T PL12708546 T PL 12708546T PL 2686334 T3 PL2686334 T3 PL 2686334T3
Authority
PL
Poland
Prior art keywords
aggregates
fragments
modulation
separation
ion exchange
Prior art date
Application number
PL12708546T
Other languages
English (en)
Other versions
PL2686334T5 (pl
Inventor
Sebastian Neumann
Original Assignee
F.Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45819216&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2686334(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by F.Hoffmann-La Roche Ag filed Critical F.Hoffmann-La Roche Ag
Publication of PL2686334T3 publication Critical patent/PL2686334T3/pl
Publication of PL2686334T5 publication Critical patent/PL2686334T5/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591—Stabilisation, fragmentation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • B01D15/362—Cation-exchange
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL12708546T 2011-03-16 2012-03-14 Chromatografia jonowymienna o ulepszonej selektywności do rozdzielania monomerów, agregatów i fragmentów polipeptydowych przez modulację fazy ruchomej PL2686334T5 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11158523 2011-03-16
EP12708546.2A EP2686334B2 (en) 2011-03-16 2012-03-14 Ion exchange chromatography with improved selectivity for the separation of polypeptide monomers, aggregates and fragments by modulation of the mobile phase
PCT/EP2012/054449 WO2012123488A1 (en) 2011-03-16 2012-03-14 Ion exchange chromatography with improved selectivity for the separation of polypeptide monomers, aggregates and fragments by modulation of the mobile phase

Publications (2)

Publication Number Publication Date
PL2686334T3 true PL2686334T3 (pl) 2018-03-30
PL2686334T5 PL2686334T5 (pl) 2020-10-19

Family

ID=45819216

Family Applications (2)

Application Number Title Priority Date Filing Date
PL17201391T PL3318571T3 (pl) 2011-03-16 2012-03-14 Chromatografia jonowymienna o ulepszonej selektywności do rozdzielania monomerów, agregatów i fragmentów polipeptydowych przez modulację fazy ruchomej
PL12708546T PL2686334T5 (pl) 2011-03-16 2012-03-14 Chromatografia jonowymienna o ulepszonej selektywności do rozdzielania monomerów, agregatów i fragmentów polipeptydowych przez modulację fazy ruchomej

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL17201391T PL3318571T3 (pl) 2011-03-16 2012-03-14 Chromatografia jonowymienna o ulepszonej selektywności do rozdzielania monomerów, agregatów i fragmentów polipeptydowych przez modulację fazy ruchomej

Country Status (9)

Country Link
US (3) US9394337B2 (pl)
EP (2) EP3318571B1 (pl)
JP (3) JP5984854B2 (pl)
ES (2) ES2865449T3 (pl)
HR (2) HRP20180028T4 (pl)
PL (2) PL3318571T3 (pl)
SG (1) SG193378A1 (pl)
SI (2) SI3318571T1 (pl)
WO (1) WO2012123488A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI3318571T1 (sl) 2011-03-16 2021-08-31 F. Hoffmann-La Roche Ag Ionska izmenjevalna kromatografija z izboljšano selektivnostjo za ločevanje polipeptidnih monomerov, agregatov in fragmentov s spremembo mobilne faze
US9573810B2 (en) * 2012-07-21 2017-02-21 K-Technologies, Inc. Processes for the removal and recovery of minor elements in wet-process phosphoric acid
JP6285532B2 (ja) 2013-03-14 2018-02-28 イー・エム・デイー・ミリポア・コーポレイシヨン タンパク質ａに基づくクロマトグラフィを使用するタンパク質純度を増加させる方法
GB2516808A (en) * 2013-05-31 2015-02-11 Innova Biosciences Ltd Antibody composition and buffer system therefor
EP3036253B1 (en) * 2013-08-19 2020-09-23 F. Hoffmann-La Roche AG Separation of bispecific antibodies and bispecific antibody production side products using hydroxyapatite chromatography
CN113388026B (zh) * 2021-08-03 2022-09-27 江西理工大学 一种螺旋藻藻蓝蛋白和藻油的同步提取方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202238A (en) 1987-10-27 1993-04-13 Oncogen Production of chimeric antibodies by homologous recombination
US5204244A (en) 1987-10-27 1993-04-20 Oncogen Production of chimeric antibodies by homologous recombination
US5429746A (en) 1994-02-22 1995-07-04 Smith Kline Beecham Corporation Antibody purification
ES2228052T3 (es) 1998-06-01 2005-04-01 Genentech, Inc. Separacion demonomeros de anticuerpos de sus multimeros utilizando cromatografia de intercambio de iones.
US6281336B1 (en) * 1998-06-09 2001-08-28 Statens Serum Institut Process for producing immunoglobulins for intravenous administration and other immunoglobulin products
ID27417A (id) 1998-06-09 2001-04-05 Statens Seruminstitut Proses untuk memproduksi immunoglobulin untuk pemberian melalui intravena dan produk-produk immunoglobulin lainnya
DE19836213A1 (de) * 1998-08-11 2000-02-24 Gerhard Harry Scholz Verfahren zur Elution von Biomolekülen von Chromatographie-Materialien
WO2004013162A2 (en) 2002-08-06 2004-02-12 Akzo Nobel Nv. Increased dynamic binding capacity in ion exchange chromatography by addition of polyethylene glycol
CN1208346C (zh) 2003-04-09 2005-06-29 中国科学院过程工程研究所 血红蛋白－人血清白蛋白偶联物制备血液代用品及其制备方法
SE0400886D0 (sv) 2004-04-02 2004-04-02 Amersham Biosciences Ab Process of purification
KR100554481B1 (ko) * 2004-06-30 2006-03-03 씨제이 주식회사 반코마이신 염산염의 정제방법
TWI320788B (en) 2005-05-25 2010-02-21 Hoffmann La Roche Method for the purification of antibodies
EP2049570B1 (en) * 2006-06-01 2016-08-10 President and Fellows of Harvard College Purification of a bivalently active antibody using a non-chromatographic method
US7691980B2 (en) 2007-01-09 2010-04-06 Bio-Rad Laboratories, Inc. Enhanced capacity and purification of antibodies by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers
EP2182943B1 (en) * 2007-07-23 2016-10-26 Janssen Biotech, Inc. Methods and compositions for treating fibrosis related disorders using il-17 antagonists
CA2709354C (en) * 2007-12-21 2014-06-17 Amgen Inc. Anti-amyloid antibodies and uses thereof
US8093364B2 (en) 2008-01-18 2012-01-10 Bio-Rad Laboratories, Inc. Enhanced purification of antibodies and antibody fragments by apatite chromatography
WO2009149067A1 (en) 2008-06-03 2009-12-10 Patrys Limited Process for purification of antibodies
BRPI0919531A2 (pt) 2008-09-29 2015-12-08 Roche Glycart Ag anticorpos contra il17 humana e usos dos mesmos
US8268314B2 (en) 2008-10-08 2012-09-18 Hoffmann-La Roche Inc. Bispecific anti-VEGF/anti-ANG-2 antibodies
PT3444335T (pt) 2009-06-16 2021-07-12 Genzyme Corp Métodos melhorados para puruficação de vetores aav recombinantes
US8394922B2 (en) * 2009-08-03 2013-03-12 Medarex, Inc. Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof
AR080793A1 (es) * 2010-03-26 2012-05-09 Roche Glycart Ag Anticuerpos biespecificos
SI3318571T1 (sl) 2011-03-16 2021-08-31 F. Hoffmann-La Roche Ag Ionska izmenjevalna kromatografija z izboljšano selektivnostjo za ločevanje polipeptidnih monomerov, agregatov in fragmentov s spremembo mobilne faze

Also Published As

Publication number Publication date
JP6273326B2 (ja) 2018-01-31
EP2686334A1 (en) 2014-01-22
SI2686334T1 (en) 2018-03-30
EP3318571A1 (en) 2018-05-09
ES2656167T5 (es) 2021-03-26
SI2686334T2 (sl) 2020-10-30
EP2686334B2 (en) 2020-07-01
JP2017019805A (ja) 2017-01-26
ES2656167T3 (es) 2018-02-23
US10377793B2 (en) 2019-08-13
JP2014511829A (ja) 2014-05-19
PL3318571T3 (pl) 2021-07-05
WO2012123488A1 (en) 2012-09-20
JP2018058900A (ja) 2018-04-12
SG193378A1 (en) 2013-10-30
US20200148719A1 (en) 2020-05-14
HRP20180028T4 (hr) 2020-10-02
JP6523491B2 (ja) 2019-06-05
SI3318571T1 (sl) 2021-08-31
US20140081000A1 (en) 2014-03-20
HRP20210588T1 (hr) 2021-05-28
ES2865449T3 (es) 2021-10-15
JP5984854B2 (ja) 2016-09-06
US9394337B2 (en) 2016-07-19
US20170107249A1 (en) 2017-04-20
EP3318571B1 (en) 2021-02-17
EP2686334B1 (en) 2017-11-15
HRP20180028T1 (hr) 2018-02-09
PL2686334T5 (pl) 2020-10-19

Similar Documents

Publication Publication Date Title
HRP20180028T1 (hr) Kromatografija izmjene iona s poboljšanom selektivnošću za odvajanje polipeptidnih monomera, agregata i fragmenata modulacijom pokretne faze
HK1208875A1 (en) Compounds & methods for the enhanced degradation of targeted proteins & other polypeptides by an e3 ubiquitin ligase e3
HRP20181846T1 (hr) Kromatografija membranom za ionsku izmjenu
DK2766395T3 (da) Antistofpolypeptider, der antagoniserer cd40l
EP2681239B8 (en) Antigen binding proteins
EP3113857A4 (en) Chromatographic materials for the separation of unsaturated molecules
IL231761A0 (en) Recombinant polycistronic RNA molecules that replicate themselves
EP2859726B8 (en) Methods for intra transform skip mode
ZA201306646B (en) Hla-restricted, peptide-specific antigen binding proteins
AP2014008053A0 (en) ST2 antigen binding proteins
EP3039463A4 (en) Dual antenna for circular polarization
IL235994A0 (en) Humanized anti-trka antibodies with amino acid substitutions
HK1198832A1 (en) Fn14 binding proteins and uses thereof fn14
ZA201401140B (en) Polypeptide separation methods
EP2896091A4 (en) Split radio architecture
HK1198588A1 (en) Protein purification by anion exchange chromatography
HK1198653A1 (en) Protein purification by anion exchange chromatography
AU2012213753A1 (en) Trifunctional crosslinking reagents
KR20180085063A (ko) 신규 단백질 소재
TWM433627U (en) Improved structure for changeover switch
AU2012902593A0 (en) Improved Recombinant Viruses
EP2660963B8 (en) Intelligent current analysis for resonant converters
AU2012904148A0 (en) Peptide sulfonation
AU2012903985A0 (en) Split Radio Architecture
AU2011901326A0 (en) Improved lagging